Finnish health tech startup Combinostics has announced the closure of a €3.9 million of Series A funding round that will see the company scale its platform for early-stage Alzheimer’s diagnosis to the US and Asia. The round was jointly-led by Industrifonden and NordicNinja VC, with Combinostics representing NordicNinja’s fifth deep tech investment over the past 6 months.
Combinostics CEO Lennart Thurfjell, said: